VX-809, soluble in DMSO and ethanol and insoluble in water, blocks the activity of the cystic fibrosis transmembrane conductance regulator protein, which plays a crucial role in the movement of chloride ions across cell membranes. It targets F508del-CFTR (Fisher rat thyroid cells).
Molecular Weight
452.4
Molecular Formula
C24H18F2N2O5
Targets
F508del-CFTR (Fisher rat thyroid cells): 0.1 μM (EC50)
VX-809 (Lumacaftor) is employed in studies as a CFTR corrector to investigate therapeutic strategies for cystic fibrosis by correcting the folding defect of mutant CFTR protein.
Publications
Publications (0)
×
Publications
Thank you for choosing our products for your research. By sharing your publications or experimental feedback, you provide invaluable insights that help fellow scientists accelerate their discoveries. Your contribution also drives our commitment to continuous product optimization.
As a token of our appreciation, verified submissions will receive an exclusive discount code for your next order.
*Submitted research data and images may be featured on our product pages. We strictly protect your personal privacy; no sensitive contact information will ever be disclosed.
CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.